Ackerman, Lindsay
Acloque, Gerard
Bacchelli, Sandro
Schwartz, Howard
Feinstein, Brian J.
La Stella, Phillip
Alavi, Afsaneh
Gollerkeri, Ashwin
Davis, Jeffrey
Campbell, Veronica
McDonald, Alice
Agarwal, Sagar
Karnik, Rahul
Shi, Kelvin
Mishkin, Aimee
Culbertson, Jennifer
Klaus, Christine
Enerson, Bradley
Massa, Virginia
Kuhn, Eric
Sharma, Kirti
Keaney, Erin
Barnes, Randy
Chen, Dapeng
Zheng, Xiaozhang
Rong, Haojing
Sabesan, Vijay
Ho, Chris
Mainolfi, Nello
Slavin, Anthony
Gollob, Jared A. http://orcid.org/0009-0008-0281-715X
Funding for this research was provided by:
Kymera Therapeutics
Article History
Received: 21 July 2023
Accepted: 6 October 2023
First Online: 13 November 2023
Competing interests
: A.G., V.C., A.D., S.A., R.K., K.S., A.M., C.K., B.E., V.M., E.K., K.S., E.K., R.B., D.C., X.Z., V.S., C.H., N.M., A.S. and J.A.G. are Kymera Therapeutics employees and may have stock or stock options. J.D. and H.R. are former Kymera Therapeutics employees and may have stock or stock options. J.C. is a full-time consultant working for Kymera Therapeutics. All other authors (L.A., G.A., S.B., H.S., B.J.F., P.L. and A.A.) are employees of their respective companies; they were investigators from clinical sites in the trial and received payment for their participation in the trial.